Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

prnasiaApril 16, 2021

Tag: Kintor , GT20029 , Acne , androgenetic alopecia

PharmaSources Customer Service